|

SSGJ-705 combined with chemotherapy Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Shenyang Sunshine Pharmaceutical Co., LTD.2

Indications

  • Cancer2
  • Locally Advanced (Unresectable) or Metastatic Solid Tumors1
  • Locally Advanced, Recurrent or Metastatic Malignancies1

Other2 trials

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Phase 2
SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.